Luteinizing hormone (LH) is a key regulator of follicular maturation, oocyte release and corpus luteum function, operating within the hypothalamic–pituitary–ovarian axis. In assisted reproductive ...

Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists? The following represents disclosure information ...

Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma A total of 501 patients were included in the analysis: 287 received ...

Background: In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human ...

The luteinizing hormone receptor (LHR) is a G protein-coupled receptor whose dynamic expression in ovarian granulosa and theca cells underpins key events in folliculogenesis, ovulation and luteal ...

Minipuberty refers to a specific period in early postnatal life with high activity of the hypothalamic–pituitary–gonadal (HPG) hormone axis. In infant boys 1 to 3 months of age, high concentrations of ...

The hypothalamus–pituitary–target gland axis has been recognized as a fundamental functional framework of the mammalian endocrine system. The anterior pituitary gland synthesizes and secretes multiple ...

For women seeking greater insight into their hormone patterns during perimenopause, the data can tell an important story. But hormone measurements alone do not fully explain anxiety that appears ...

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...

The 20 participants completing the study had a mean age of 59 years (range 51–69). As expected due to random group assignment, baseline values of urinary LH excretion among the 3 groups were not ...